A microneutralization enzyme-linked immunosorbent assay (ELISA) was developed to detect specific antibodies to bovine respiratory syncytial viruses (BRSVs) in cattle sera using a monoclonal antibody to the fusion protein of the virus. Serum from 20 naturally exposed, 24 experimentally infected, and 15 immunized cattle were evaluated using 3 different BRSV isolates. Antibody titers determined with the microneutralization ELISA were compared with those derived from a classical virus neutralization assay, an indirect ELISA, and a fusion inhibition assay. These studies demonstrated a high degree of correlation (usually 0.90) among the assays. Furthermore, the results showed that immunization of cattle with one isolate (subgroup) of BRSV induced antibody responses that cross-reacted with at least 2 disparate isolates. These results document the utility of the microneutralization ELISA in assessing functionally important antibody responses to BRSVs in cattle.
Bovine respiratory syncytial viruses (BRSVs) acting alone and in concert with other pathogens are important causes of respiratory disease in cattle. 1 Because of their labile nature, BRSVs are rarely isolated from clinical specimens; therefore, serology is most often used to diagnose infections. 1, 8 Numerous serologic assays have been developed to detect antibody responses to BRSV in infected cattle, including virus neutralization (VN), 4 complement fixation, 11 enzyme-linked immunosorbent assay (ELISA), 11 competitive (blocking) ELISA specific for the fusion (F) protein, 18 and isotypespecific ELISA. 22 Because the ELISA lends itself well to automation, it has many advantages over the classical VN test. However, although ELISA is a relatively rapid and repeatable method of detecting antibody responses to BRSV, there is evidence that there can be a disparity between the concentrations of neutralizing antibodies and total BRSV-reactive IgG, as detected by ELISA, in naturally infected cattle 11 and in cattle that receive various inactivated vaccines. 9 Because antibodies capable of virus neutralization or fusion inhibition may play a role in reducing the severity of disease following BRSV infection 1,12 assays that measure the specific functions of antibodies have an important role in qualitatively assessing a BRSV-specific immune response.
Recently, and in parallel with the documented het-erogeneity of human respiratory syncytial viruses (HRSVs), 1,17 2 different subgroups of BRSV have been described on the basis of differences in the phosphoprotein and F protein. 5 Although there is evidence of differential pathogenicity among HRSV isolates, 16 the clinical relevance of subgroups of BRSV is poorly understood. Analysis of respiratory syncytial viruses (RSVs) indicates that much of their antigenic diversity resides in differences in the large glycoprotein (G) that mediates virus attachment to target cells and that there is considerable conservation among antigenic determinants on the F protein. This similarity in F proteins is found not only among isolates infecting a single species or related species, such as BRSV, but also among isolates infecting different species, such as BRSV and HRSV. 5, 15, 19 Although murine and bovine monoclonal antibodies specific for F proteins of RSVs are crossreactive and cross-protective among various isolates and species of RSVs, 19 there is little information concerning the cross-reactive and cross-protective nature of BRSV-specific serum antibodies in the natural bovine host, particularly with regard to the ability of BRSV vaccines to induce cross-reactive responses.
The purpose of this investigation was to develop a microneutralization test that combined the functional assessment of VN and technical advantages of ELISA. A microneutralization ELISA was compared to the classical VN test, a fusion inhibition assay, and an indirect ELISA for the detection of BRSV-specific antibodies in cattle sera. Furthermore, the microneutralization ELISA was used to determine whether a vaccine that contains a single isolate of BRSV is capable of inducing antibody responses that neutralize antigenically disparate isolates of BRSVs.
Materials and methods
Viruses and cells. The following 3 isolates of BRSVs were used: 1) a vaccine strain a that is a derivative of the 375 isolate (SBAH-375), 13 2) the Minnesota isolate (MN), 4 and 3) a vaccine strain b that is a derivative of RB94 (SBAH-RB94). 21 The SBAH-375 and MN isolates were selected as representatives of 2 subgroups of BRSV that have F proteins of different molecular weights. 5 The SBAH-RB94 virus is a European vaccine strain, and its relationship to the other 2 isolates is not well defined. The BRSVs were grown and titered by plaque assays in embryonic bovine turbinate (EBT) cells or Maden Darby bovine kidney (MDBK) cells.
Indirect ELISA. An indirect ELISA for BRSV antibodies was performed according to previously described methods 11 using duplicate serum samples diluted 1/50. This assay utilized partially purified virus derived from lysed and ultracentrifuged Vero cells infected with SBAH-375. Lysed ultracentrifuged, uninfected Vero cells were used as control antigen. The concentration of BRSV-specific antibodies was expressed as units generated by linear regression analysis utilizing a standard curve obtained from dilutions of a positive control serum. If the antibody concentration was approximated as a negative value from the regression line, then the concentration was considered to be 0.
Bovine sera. Twenty bovine sera were selected from cases submitted to the diagnostic virology laboratory at the Westem College of Veterinary Medicine. The basis for selection of these samples was inclusion of a wide range of values obtained in the indirect ELISA specific for antibodies to BRSV.
Twenty-four sera were from 6-month-old calves that were inoculated intratracheally and intranasally with 10 6 TCID 50 of a low-passage field isolate, SBAH-165 (provided by Dr. M. O'Hara, a in 10 ml of medium. Nasal shedding of BRSV was monitored for 14 days after infection, and the presence of BRSV in nasal secretions was confirmed on 1 or more days after infection. Sera were collected on day 14 after infection.
Fifteen sera were from calves approximately 6 months old that were immunized 10 days after weaning and again 14 days after the first immunization with a polyvalent vaccine a containing SBAH-375. Five age-matched cattle served as commingled unvaccinated controls in this experiment. Serum was collected on the day of the first dose and 12 days after the second dose. Serum used as a positive control was obtained from a steer convalescing from a naturally acquired BRSV infection. This serum had high concentrations of BRSV-specific antibodies, as determined by an indirect ELISA and VN test, and was used throughout the study as a positive control. A negative control serum lacking in detectable antibodies to BRSV by indirect ELISA and VN tests was obtained from an adult cow.
VN test. Virus neutralizing antibodies in serum were measured using a microtiter plaque reduction assay that was performed according to previously described methods 12 using each of the 3 isolates of BRSV grown in MDBK cells or EBT cells. Heat inactivated (for 30 min at 56 C) serum samples were tested in duplicate, and serum was diluted using 3-fold serial dilutions (1:3-1:81). Samples were further diluted 1:1 with cultured virus so that the reciprocal dilutions tested were 6, 18, 54, and 162. Microtiter plates were evaluated for cytopathic effects (CPE) at 5 days after the initiation of cultures. Titers were recorded as the last dilution that yielded positive results (neutralization of infectivity) in both replicates. If only 1 replicate of a dilution showed CPE, the sample was considered to have a titer midway between the actual dilution and the next lower dilution. For the purpose of analyses, VN reciprocal titers were coded; titers recorded as < 6, 6, 12, 18, 36, 54, 108, 162, and > 162 were assigned codes of 0, 1, 2, 3, 4, 5, 6, 7, or 8, respectively. 20 Microneutralization ELISA. Microtiter plates used for the classical VN test were further processed for ELISA using a modification of previously described methods. 2 Plates were washed 3 times in 0.1 M phosphate-buffered saline (PBS) (pH 7.2) containing 0.05% Tween 20 (PBST) and the cell monolayers were fixed by application of 80% (v/v) acetone in PBS for 5 min at room temperature. Monolayers were air dried and used immediately or stored at 4 C until use. Immediately prior to staining, wells were blocked for 30 minutes at 37 C with 200 µl of 0.5% gelatin in PBS to reduce nonspecific binding. After washing 3 times with PBST, monolayers were reacted with 75 µl of ascitic fluid containing a monoclonal antibody (no. 19) c,19 specific for the fusion protein of BRSVs that was diluted 1:800 in PBST containing 0.5% gelatin and 2% normal rabbit serum. After 1 hr at 37 C, the microtiter plates were washed 3 times in PBST, 75 µl of peroxidase-conjugated F(ab') 2 fragments of rabbit antimouse IgGd diluted 1:10,000 in PBST containing 0.5% gelatin and 2% normal rabbit serum was added to each well, and plates were sealed and incubated for 1 hr at 37 C. The microtiter plates were washed 3 times with PBST, and 100 µl of o-phenylenediamine dihydrochloride was added to each well for approximately 5 min prior to stopping the enzymatic reaction with 50 µl of 5 N HCl. The optical density (OD) in individual wells was read at 490 nm.
Each set of assays contained the following controls: uninfected EBT cells with dilutions of fetal bovine serum, uninfected EBT cells with dilutions of normal (BRSV seronegative) bovine serum, EBT cells infected with the respective isolate of BRSV in normal bovine serum, EBT cells infected in BRSV-seropositive (completely neutralizing) serum, and a back titration of BRSV in fetal bovine serum. The incubation of uninfected EBT (and MDBK) cells with sera from weanling or adult cattle consistently gave higher levels of background staining than did similar wells containing fetal calf serum (Fig. 1 ). To account for background staining contributed by bovine serum and cellular components in the respective viral inocula, an absorbance above the mean of control wells containing a 1:3 dilution of the standard bovine immune (completely neutralizing) serum and the input dilution of the respective viral inocula was considered to be evidence of viral replication and was used as a cutoff value ( Fig. 1) .
Antibody titers were determined in a manner similar to that for the VN test. Titers were recorded as the last dilution that had OD values equal to or less than the cutoff OD value in both replicates. If only one replicate of a dilution had OD values equal to or less than the cutoff OD value, the sample was considered to have a titer midway between the actual Initial studies using MDBK cells as target cells in the microneutralization ELISA indicated that although, as others have reported (L. Nelson, personal communication, 1993) , the BRSV isolates that we used tended to grow to higher titers in MDBK cells than in EBT cells, visual detection of CPE 5 days after infection was more difficult using the MDBK cells. In addition, the use of these cells yielded higher background staining in the ELISA. dilution and the next lower dilution. For the purpose of analagainst BRSV F protein. This staining of BRSV-infected cells yses, reciprocal titers were coded; titers recorded as <6, 6, by the conjugate was attributed to RSV-specific antibodies 12, 18, 36, 54, 108, 162, and > 162 were assigned codes of in the goat serum, probably resulting from natural exposure 0, 1, 2, 3, 4, 5, 6, 7, or 8, respectively. 20 of the caprine serum donors. 14 Fusion inhibition assay. An assay to detect antibodies that inhibit BRSV-mediated fusion was conducted using a modification of previously described techniques? Monolayers of EBT cells (approximately 50% confluent) were infected with approximately 120 TCID 50 of SBAH-RB94 at 37 C. SBAH-RB94 was used because it was apparently more fusigenic than were the other isolates tested. After 2 hr, the inoculum was removed, and the monolayers were washed for 2 hr with Eagle's modified minimal essential medium to remove unabsorbed virus. Serial 3-fold dilutions of bovine serum were then added to each well. When cells in medium with normal bovine serum developed large syncytia 5 days later, the medium was removed, and the monolayers were fixed in 80%
In preliminary studies, goat anti-mouse IgG antibody was used as a conjugate in the microneutralization ELISA. 20 This conjugate resulted in higher than acceptable levels of background staining and also stained BRSV-infected EBT cells in the absence of the primary mouse monoclonal antibody acetone in distilled water. Monolayers were stained with Giemsa and evaluated for the absence of multinucleated giant cells, which was considered an indication of fusion inhibition. The end point titer of fusion-inhibiting antibodies was determined as for the VN test by comparing test wells with control wells that contained normal bovine serum.
Statistical analyses. The correlation between geometric mean titers calculated for the various serologic methods were compared in pair-wise fashion using least-squares linear regression analysis and expressed as a correlation coefficient (I?) for which a perfect straight line would be R = 1 . e Paired Student's t-tests were used to test for differences in group geometric mean antibody titers between assays conducted at different times. e The abilities of the postvaccinal bovine sera to neutralize the 3 BRSVs were compared using an analysis of variance (ANOVA). e The critical alpha level for significance of differences was set at P = 0.05.
Results
Detection of BRSV-neutralizing antibodies in field sera. Twenty bovine serum samples with a wide range of BRSV-specific antibodies, as determined by indirect ELISA, were tested with the microneutralization ELISA on 2 separate days using 2 different batches of SBAH-375 BRSV at different dilutions. The back titrations of BRSV were 40 and 240 TCID 50 , respectively. The microneutralization ELISA detected concentrations of BRSV-specific neutralizing antibodies (Fig. 1) that closely corresponded to the titers obtained using an indirect ELISA (R = 0.94), and there was a high degree of correlation (R = 0.97) between the results of the microneutralization ELISA and those obtained by assessing the CPE in the VN test. Similarly there was a high degree of correlation (R = 0.96) when results of the microneutralization ELISA and the VN test were compared using 24 sera from cattle that produced BRSV-specific antibodies in response to experimental infection.
Comparison of the results of the microneutralization ELISA and the VN assays indicated that the microneutralization ELISA detected single viral plaques as determined by visual assessment. Moreover, there were no significant differences between the geometric mean titers of the microneutralization ELISAs performed on the 2 days using different batches and dilutions of BRSV.
Quantitation of cross-neutralizing antibodies following immunization. The microneutralization ELISA detected rising neutralizing antibody titers in cattle that were immunized with a polyvalent modified-live vaccine containing SBAH-375 BRSV when the SBAH-375 virus was used in the assay (Fig. 2) . These titers were significantly lower (P < 0.05) than those in sera from unvaccinated commingled control cattle (data not presented). As with the sera from naturally exposed cattle, there was a high degree of correlation (R = 0.88) between the microneutralization ELISA and the indirect ELISA and a high degree of correlation (R = 0.95) between the results obtained using the microneutralization ELISA and those from assessing CPE in the VN test (Fig. 3) . The use of the MN and SBAH-RB94 isolates in microneutralization ELISAs demonstrated that antibodies induced by immunization with the modified-live SBAH-375 virus similarly crossneutralized these other disparate strains of BRSV. Furthermore, the ANOVA indicated that there were no significant differences in the capacities of the postvaccinal serum samples to cross-neutralize viral infectivity among the isolates tested. In each case, there was a high degree of correlation (MN: R = 0.94, SBAH-RB94: R = 0.95) between the magnitude of titers determined by the microneutralization ELISA and by the classical VN assay with all isolates tested (Fig. 3) .
Correlation between virus neutralizing and fusioninhibiting antibody responses. The levels of virus neutralizing and fusion-inhibiting antibodies in pre-and postvaccinal sera were compared using the microneutralization ELISA and a fusion inhibition (FI) assay. The same batch and dilution of SBAH-RB94 BRSV was used in both assays. No fusion-inhibiting anti- Figure 3 . Comparison of titers obtained by the assessment of cytopathic effect versus microneutralization ELISA for the quantitation of BRSV-specific antibodies before and after immunization with modified-live SBAH-375 using linear regression analysis. Assays are compared using the following BRSVs (back titers of input virus are indicated in brackets). a. SBAH-375 (60 TCID 50 /ml). b. MN (80 TCID 50 /ml). c. SBAH-RB94 (160 TCID 50 /ml).
bodies were detected in the sera prior to immunization. Although the vaccine-induced FI titers tended to be 2-3 dilutions lower than VN titers, there was a high degree of correlation (R = 0.90) between the 2 assays ( Fig. 4) .
Discussion
Because of the potential role of neutralizing antibodies in reducing the severity of disease following infection of cattle with BRSVS, 7,12 accurate quantitation of these antibodies is important in clinical virology studies and in vaccine assessment. Although reliable techniques to measure BRSV-neutralizing antibodies are available, they are labor intensive and are usually based on highly subjective observations, making the standard plaque reduction assay (and the FI assay) dependent on the judgment of the investigator. The microneutralization ELISA described herein utilized the same initial steps as the plaque reduction assay. However, a reduction in viral replication was objectively quantitated by a decrease in viral antigen production using ELISA as opposed to the visual assessment of virus-induced CPE. The procedure was less labor intensive and the results were obtained in a mechanized, objective fashion.
For the purposes of this comparison, the microneutralization ELISA was performed to yield results in a form (end point titration) similar to that of the VN test. Although the microneutralization technique has advantages over the VN test when performed as described, it could easily be performed in a more efficient manner to provide continuous rather than ordinal (categorical) results. Similar to the method used for indirect ELISA, a standard curve could be established for every plate, using dilutions of standard BRSV-seropositive serum. The antibody concentration of a limited number of dilutions of test sample would then be determined from the regression equation of the standard curve. Titration of the sample to reaction end would therefore be unnecessary, and the antibody concentration of a serum sample could theoretically be determined by testing a single dilution. It may be necessary to test several dilutions of test sample to ensure that the OD of the reaction lay within the range of values for the standard curve, but this would still be more efficient than using a titration result.
Although not reflected in a statistical assessment of the data, 2 potential problems were noted with interpretation of the microneutralization ELISA as compared with the classical VN test, both at lowest dilutions of bovine sera tested. First, some bovine sera were toxic to the EBT cells at the lowest final dilution tested. This toxic effect can be differentiated from the CPE produced by BRSV infection by visual assessment of the cells during the standard VN test. Cellular toxicity yielded false-positive results for neutralizing antibody at the lowest dilutions of a minority of sera tested; viral antigen was not produced in those wells in which the target cells had died. This result was reflected in OD values that were below the cutoff value for viral replication and could be interpreted as indicative of the presence of neutralizing antibodies. Sec-ond, some of bovine sera gave high background staining at low (1:3) dilutions. In sera with high concentrations of neutralizing antibodies, this resulted in higher OD values in wells containing the lowest dilutions of sera compared with higher serial dilutions that still completely neutralized virus infectivity. This background staining was invariably abrogated with dilution of sera. Previous studies have reported a poor correlation between the VN test and an indirect ELISA when examining sera from feedlot cattle, 11 and it has been suggested that high background staining due to unidentified components in sera from weaning and adult cattle (compared with fetal calf serum) is at least partially responsible for this apparent disparity between assays. 18 Our results support this hypothesis. To account for generally higher levels of background staining with field sera, we used a cutoff value that was determined on the basis ODs in wells containing target cells, a low dilution of standard BRSV-neutralizing bovine antiserum, and the dilution of virus inoculum used in the assay. This procedure gave a consistent and more relevant cutoff value than that derived using a cell control (background) containing target cells and fetal calf serum, as previously described in a microneutral-ization ELISA for HRSV. 2 The close correspondence between the VN test and the microneutralization ELISA results demonstrated the validity of this approach when using the microneutralization ELISA with clinical bovine samples as opposed to monoclonal antibodies. 2 Specific epitopes on the envelope glycoproteins of BRSVs that induce protective antibody responses in cattle remain to be defined. Moreover, how differences in glycoproteins that define subgroups of HRSVs and BRSVs may relate to differences in pathogenicity is not well understood. 2, 5, 15, 16 Subsequent to the recent definition of subgroups of BRSV, there has been a concern that vaccines containing only 1 subgroup may not induce cross-reactive responses to viruses in different group. 5 Our results, based on experiments with representatives of 2 subgroups of BRSVs that have F proteins of different molecular weights (SBAH-375 and MN), suggest that cattle immunized with 1 subgroup can mount antibody responses that cross-neutralize viruses with epitopic differences in envelope glycoproteins. Others have reported a dissociation between the recognition of epitopes involved in fusion and those involved in neutralization. 19 Those studies included an analysis of the protective functions of bovine and mu-rine monoclonal antibodies in mice with experimental Baker JC, Wilson EG, McKay GL, et al.: 1982 , Identification of subgroups of bovine respiratory syncytial virus. J Clin Microbiol 30:1120 Microbiol 30: -1126 HRSV infections and documented that antibodies recognizing fusion epitopes on the F protein were critical in protection. 19 These results should serve as a caveat relevant to the development of subunit and peptide vaccines for use in cattle and human beings. However, the results of this study, indicating a high degree of correlation between the induction of virus-neutralizing and fusion-inhibiting antibodies in response to immunization of cattle, suggest that the polyclonal antibody response in most cattle to unaltered or modified-live BRSVs comprises responses to epitopes that mediate both viral infectivity and fusion of infected target cells. Furthermore, the results suggest that a dissociation between virus-neutralizing and fusion-inhibiting antibody responses is probably not a practical concern in most cattle that are immunized with conventional livevirus vaccines, because the response is likely to comprise antibodies that recognize viral epitopes involved in both viral infectivity and fusion of target cells. However, the former possibility cannot be completely discounted in view of the probable wide variation in epitope-specific responses among genetically diverse cattle.
